Methylphenidate Decreased the Amount of Glucose Needed by the Brain to Perform a Cognitive Task
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The use of stimulants (methylphenidate and amphetamine) as cognitive enhancers by the general public is increasing and is controversial. It is still unclear how they work or why they improve performance in some individuals but impair it in others. To test the hypothesis that stimulants enhance signal to noise ratio of neuronal activity and thereby reduce cerebral activity by increasing efficiency, we measured the effects of methylphenidate on brain glucose utilization in healthy adults. We measured brain glucose metabolism (using Positron Emission Tomography and 2-deoxy-2[18F]fluoro-D-glucose) in 23 healthy adults who were tested at baseline and while performing an accuracy-controlled cognitive task (numerical calculations) given with and without methylphenidate (20 mg, oral). Sixteen subjects underwent a fourth scan with methylphenidate but without cognitive stimulation. Compared to placebo methylphenidate significantly reduced the amount of glucose utilized by the brain when performing the cognitive task but methylphenidate did not affect brain metabolism when given without cognitive stimulation. Whole brain metabolism when the cognitive task was given with placebo increased 21% whereas with methylphenidate it increased 11% (50% less). This reflected both a decrease in magnitude of activation and in the regions activated by the task. Methylphenidate's reduction of the metabolic increases in regions from the default network (implicated in mind-wandering) was associated with improvement in performance only in subjects who activated these regions when the cognitive task was given with placebo. These results corroborate prior findings that stimulant medications reduced the magnitude of regional activation to a task and in addition document a "focusing" of the activation. This effect may be beneficial when neuronal resources are diverted (i.e., mind-wandering) or impaired (i.e., attention deficit hyperactivity disorder), but it could be detrimental when brain activity is already optimally focused. This would explain why methylphenidate has beneficial effects in some individuals and contexts and detrimental effects in others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic diagram of experimental procedure. Placebo (PL) or methylphenidate (MP) was given 60 minutes prior to initiation of Cognitive or Neutral tasks, which lasted 45 minutes. [18F]FDG was injected 15 minutes after task initiation (75 minutes after MP or PL) and scans were started 35 minutes after injection.](https://figures.cochat.ai/paper-figures/67c2859daa0b42c792b7cd2b0ca426cc/methylphenidate-decreased-the-amount-of-glucose-needed-by-the-brain-to-perform-a-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the basis of PET imaging studies, it has been hypothesized that stimulant medications may act by facilitating the engagement of a dorsal task-positive attention network and the deactivation of the ventral resting state network or DMN (Volkow et al, 2008).”
From Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) · cites this paper as Volkow et al, 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This suggests that, compared with placebo, MP reduced (focused) the use of attentional resources in the human brain that are necessary to achieve similar levels of performance on a task.”
From Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) · cites this paper as Volkow et al, 2008
In the citing paper
“compared with placebo, MP significantly reduced the amount of glucose utilized by the brain when performing the task (the increase was reduced by about 50%).”
From Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) · cites this paper as Volkow et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688 · cited 8×
“Also we only consider significant findings that were corroborated both by SPM and ROI analysis.”
MethodInfluentialThe human brain is intrinsically organized into dynamic, anticorrelated functional networks
Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C., & Raichle, M. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504136102 · Cited by 8,553
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Automated Talairach Atlas labels for functional brain mapping
Lancaster, J. L., Woldorff, M. G., Parsons, L. M., Liotti, M., Freitas, C. S., Rainey, L., Kochunov, P. V., Nickerson, D., Mikiten, S. A., & Fox, P. T. (2000) · Human Brain Mapping · doi:10.1002/1097-0193(200007)10:3<120::aid-hbm30>3.0.co;2-8 · Cited by 3,387
Searching for a baseline: Functional imaging and the resting human brain
Gusnard, D. A., & Raichle, M. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094500 · Cited by 3,371
Wandering minds: the default network and stimulus-independent thought
Mason, M. F., Norton, M. I., Van Horn, J. D., Wegner, D. M., Grafton, S. T., & Macrae, C. N. (2007) · Science · doi:10.1126/science.1131295 · Cited by 2,792 · cited 1×
“The dorsal and posterior CG, the paracentral lobule and the inferior parietal cortices are regions that form part of the default network, which is deactivated when performing a task[24] and activated during mind-wandering (BA 31, 29, 30)[25].”
BackgroundFox, P. T., & Raichle, M. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1140 · Cited by 2,056 · cited 1×
“Moreover, regional CBF may become uncoupled from metabolism during stimulation[12,13].”
BackgroundThe activation of attentional networks
FAN, J., MCCANDLISS, B., FOSSELLA, J., FLOMBAUM, J., & POSNER, M. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.004 · Cited by 1,737 · cited 1×
“This study documents that when MP was given with a cognitive task it markedly attenuated the brain metabolic increases induced by the task and reduced the regions activated by it. The reduction in activation with MP included the parietal cortex, cingulate gyrus and thalamus, which are regions involved in the orienting…”
ResultThe principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592 · cited 1×
“Synaptic levels of DA and NE, which are increased by MP[5], under physiological conditions act primarily as neuromodulators changing the efficacy of other transmitter signals[14,15] as a function of ongoing neuronal activity[16].”
Background
Cited by
Liddle, E. B., Hollis, C., Batty, M. J., Groom, M. J., Totman, J. J., Liotti, M., Scerif, G., & Liddle, P. F. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02333.x · Cited by 281
Peterson, B. S., Potenza, M. N., Wang, Z., Zhu, H., Martin, A., Marsh, R., Plessen, K. J., & Yu, S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08050724 · Cited by 261
Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation
Wood, S., Sage, J. R., Shuman, T., & Anagnostaras, S. G. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007054 · Cited by 259
Swanson, J., Baler, R. D., & Volkow, N. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.160 · Cited by 252
Self-citationSedentariness and Health: Is Sedentary Behavior More Than Just Physical Inactivity?
Panahi, S., & Tremblay, A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00258 · Cited by 240
Hannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236
Arria, A. M., & DuPont, R. L. (2010) · Journal of Addictive Diseases · doi:10.1080/10550887.2010.509273 · Cited by 189
Hoekzema, E., Carmona, S., Ramos‐Quiroga, J. A., Richarte Fernández, V., Bosch, R., Soliva, J. C., Rovira, M., Bulbena, A., Tobeña, A., Casas, M., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22250 · Cited by 170
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
Sharif, S., Guirguis, A., Fergus, S., & Schifano, F. (2021) · Brain Sciences · doi:10.3390/brainsci11030355 · Cited by 166
Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies
Linssen, A. M. W., Sambeth, A., Vuurman, E. F. P. M., & Riedel, W. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001594 · Cited by 159
Tomasi, D., Volkow, N. D., Wang, R., Telang, F., Wang, G.-J., Chang, L., Ernst, T., & Fowler, J. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006102 · Cited by 154
Self-citationTomasi, D., Volkow, N. D., Wang, G. J., Wang, R., Telang, F., Caparelli, E. C., Wong, C., Jayne, M., & Fowler, J. S. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.10.060 · Cited by 145
Self-citationAn information-theoretic perspective on the costs of cognition
Zénon, A., Solopchuk, O., & Pezzulo, G. (2019) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2018.09.013 · Cited by 139
Thome, J., Ehlis, A.-C., Fallgatter, A. J., Krauel, K., Lange, K. W., Riederer, P., Romanos, M., Taurines, R., Tucha, O., Uzbekov, M., et al. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.690535 · Cited by 130
“There is evidence from fMRI and positron emission tomography (PET) data that methylphenidate supports downregulation of the DMN and leads to more focused processing in face of a task (Volkow et al. 2008; Peterson et al. 2009).”
BackgroundGoldstein, R. Z., Woicik, P. A., Maloney, T., Tomasi, D., Alia-Klein, N., Shan, J., Honorio, J., Samaras, D., Wang, R., Telang, F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011455107 · Cited by 121
Self-citationSchulz, K. P., Fan, J., Bédard, A.-C. V., Clerkin, S. M., Ivanov, I., Tang, C. Y., Halperin, J. M., & Newcorn, J. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2053 · Cited by 114
Volkow, N. D., Tomasi, D., Wang, G.-J., Fowler, J. S., Telang, F., Goldstein, R. Z., Alia-Klein, N., Woicik, P., Wong, C., Logan, J., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.30 · Cited by 109
Self-citationKonova, A. B., Moeller, S. J., Tomasi, D., Volkow, N. D., & Goldstein, R. Z. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1129 · Cited by 102
Self-citationAgay, N., Yechiam, E., Carmel, Z., & Levkovitz, Y. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1853-4 · Cited by 101
Li, C.-S. R., Morgan, P. T., Matuskey, D., Abdelghany, O., Luo, X., Chang, J. L. K., Rounsaville, B. J., Ding, Y.-S., & Malison, R. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002467107 · Cited by 97
Do college students improve their grades by using prescription stimulants nonmedically?
Arria, A. M., Caldeira, K. M., Vincent, K. B., O’Grady, K. E., Cimini, M. D., Geisner, I. M., Fossos‐Wong, N., Kilmer, J. R., & Larimer, M. E. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.07.016 · Cited by 119
Weyandt, L. L., Marraccini, M. E., Guðmundsdóttir, B. G., Zavras, B. M., Turcotte, K., Munro, B. A., & Amoroso, A. J. (2013) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0034013 · Cited by 101
Linssen, A. M. W., Vuurman, E. F. P. M., Sambeth, A., Nave, S., Spooren, W., Vargas, G., Santarelli, L., & Riedel, W. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2345-x · Cited by 82
Moeller, S. J., Honorio, J., Tomasi, D., Parvaz, M. A., Woicik, P. A., Volkow, N. D., & Goldstein, R. Z. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs345 · Cited by 80
Self-citationFassbender, C., Schweitzer, J. B., Cortes, C. R., Tagamets, M. A., Windsor, T. A., Reeves, G. M., & Gullapalli, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027240 · Cited by 72
“g [14,36]).”
Arria, A. M., Geisner, I. M., Cimini, M. D., Kilmer, J. R., Caldeira, K. M., Barrall, A. L., Vincent, K. B., Fossos‐Wong, N., Yeh, J., Rhew, I. C., et al. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.07.013 · Cited by 90
Dopaminergic involvement during mental fatigue in health and cocaine addiction
Moeller, S. J., Tomasi, D., Honorio, J., Volkow, N. D., & Goldstein, R. Z. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.110 · Cited by 72
Self-citationVolkow, N. D., Tomasi, D., Wang, G.-J., Telang, F., Fowler, J. S., Wang, R. L., Logan, J., Wong, C., Jayne, M., & Swanson, J. M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.003 · Cited by 68
Self-citationEffects of chronic and acute stimulants on brain functional connectivity hubs
Konova, A. B., Moeller, S. J., Tomasi, D., & Goldstein, R. Z. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.002 · Cited by 61
Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers
Volkow, N. D., Wang, G.-J., Tomasi, D., Telang, F., Fowler, J. S., Pradhan, K., Jayne, M., Logan, J., Goldstein, R. Z., Alia-Klein, N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011509 · Cited by 59
Self-citationShah, R., Matthews, D., Andrews, R., Capuano, A., Fleischman, D., VanderLugt, J., & Colca, J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140616113406 · Cited by 57
Kim, J., Whyte, J., Patel, S., Europa, E., Wang, J., Coslett, H. B., & Detre, J. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2622-8 · Cited by 55
Methylphenidate as a cognitive enhancer in healthy young people
Batistela, S., Bueno, O. F. A., Vaz, L. J., & Galduróz, J. C. F. (2016) · Dementia & Neuropsychologia · doi:10.1590/s1980-5764-2016dn1002009 · Cited by 53
“Volkow et al. (2008)33 suggested that the effects of stimulants can be beneficial when neural resources are focused elsewhere or are adversely affected, but can have adverse effects when cerebral activity is already at an optimal level of focus.”
BackgroundMarraccini, M. E., Weyandt, L. L., Rossi, J. S., & Guðmundsdóttir, B. G. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000079 · Cited by 57
An Integrated Perspective of Effort and Perception of Effort
Halperin, I., & Vigotsky, A. D. (2024) · Sports Medicine · doi:10.1007/s40279-024-02055-8 · Cited by 84
Potentially Inappropriate Medication Use in Older Adults With Mild Cognitive Impairment
Weston, A. L., Weinstein, A. M., Barton, C., & Yaffe, K. S. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp158 · Cited by 59
Frölich, J., Banaschewski, T., Döpfner, M., & Görtz‐Dorten, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.922542 · Cited by 42
Hearne, L. J., Lin, H., Sanz‐Leon, P., Tseng, W. I., Gau, S. S., Roberts, J. A., & Cocchi, L. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0554-6 · Cited by 43
Bubl, E., Dörr, M., Riedel, A., Ebert, D., Philipsen, A., Bach, M., & van Elst, L. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118271 · Cited by 39
Michaelides, M., Pascau, J., Gispert, J., Delis, F., Grandy, D. K., Wang, G., Desco, M., Rubinstein, M., Volkow, N. D., & Thanos, P. K. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07319.x · Cited by 35
Self-citationDeficits in default mode network activity preceding error in cocaine dependent individuals
Bednarski, S. R., Zhang, S., Hong, K., Sinha, R., Rounsaville, B. J., & Li, C. R. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.05.026 · Cited by 40
Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
Kapur, A. (2020) · CNS Drugs · doi:10.1007/s40263-020-00758-w · Cited by 38
Nicotinic Receptors and Attention
Hahn, B. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_5 · Cited by 34
Abelman, D. D. (2017) · Harm Reduction Journal · doi:10.1186/s12954-017-0194-6 · Cited by 47
Goldstein, R. Z., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.145 · Cited by 32
Self-citationDecision making: effects of methylphenidate on temporal discounting in nonhuman primates
Rajala, A. Z., Jenison, R. L., & Populin, L. C. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00278.2015 · Cited by 25
Froestl, W., Pfeifer, A., & Muhs, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121729 · Cited by 33
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26
Nakanishi, Y., Ota, T., Iida, J., Yamamuro, K., Kishimoto, N., Okazaki, K., & Kishimoto, T. (2017) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-017-0163-6 · Cited by 25
Absent without leave; a neuroenergetic theory of mind wandering
Killeen, P. R. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00373 · Cited by 26
High reward expectancy during methylphenidate depresses the dopaminergic response to gain and loss
Evers, E. A. T., Stiers, P. L. J., & Ramaekers, J. G. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw124 · Cited by 25
Mommaerts, J.-L., Beerens, G., den Block, L. V., Soetens, E. L. L., Schol, S., Vijver, E. V. D., & Devroey, D. (2013) · Psychology Research and Behavior Management · doi:10.2147/prbm.s47526 · Cited by 25
Ramasubbu, R., Singh, H., Zhu, H., & Dunn, J. F. (2012) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2258 · Cited by 20
Tomasi, D. G., Wang, G.-J., & Volkow, N. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.93 · Cited by 23
Self-citationMicoulaud, F. G. (2015) · Journal of Clinical Research & Bioethics · doi:10.4172/2155-9627.1000213 · Cited by 29
Murphy, A., Dursun, S. M., McKie, S., Elliott, R., & Deakin, J. F. W. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4234-9 · Cited by 20
Alzoubi, A., Nasor, E. M., Suliman, E. M., Alqaderi, N., Abbastanira, S. H. I., Abdi, S. A. H., Mustafa, S., & Kheirallah, K. A. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s405279 · Cited by 25
Krauel, K., Düzel, E., Hinrichs, H., Lenz, D., Herrmann, C. S., Santel, S., Rellum, T., & Baving, L. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.02.030 · Cited by 20
Normalization of increased retinal background noise after ADHD treatment: A neuronal correlate
Werner, A. L., van Elst, L. T., Ebert, D., Friedel, E. B. N., Bubl, A., Clement, H., Lukačin, R., Bach, M., & Bubl, E. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.04.013 · Cited by 19
Cognition-Enhancing Drugs and Their Appropriateness for Aviation and Ground Troops: A Meta-Analysis
Kelley, A. M., Webb, C. M., Athy, J. R., Ley, S. L., & Gaydos, S. (2010) · Defense Technical Information Center (DTIC) · doi:10.21236/ada533727 · Cited by 19
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
Senior, D., Ahmed, R., Arnavut, E., Carvalho, A. T. P., Lee, W. X., Blum, K., Komatsu, D. E., Hadjiargyrou, M., Badgaiyan, R. D., & Thanos, P. K. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040574 · Cited by 16
Manza, P., Hu, S., Ide, J. S., Farr, O. M., Zhang, S., Leung, H., & Li, C. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115625102 · Cited by 16
Patrick, K. S., Radke, J. L., Raymond, J. R., Koller, L., Nguyen, L. V., Rodriguez, W., & Straughn, A. B. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2190 · Cited by 18
Demiral, Ş. B., Tomasi, D. G., Wiers, C. E., Manza, P., Kojori, E. S., Studentsova, Y., Wang, G., & Volkow, N. D. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0287-2 · Cited by 14
Self-citationMethylphenidate modulates interactions of anxiety with cognition
Gaillard, C., Lago, T. R., Gorka, A. X., Balderston, N. L., Fuchs, B. A., Reynolds, R. C., Grillon, C., & Ernst, M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01621-2 · Cited by 14
Neural basis for individual differences in the attention-enhancing effects of methylphenidate
Manza, P., Tomasi, D. G., Demiral, Ş. B., Kojori, E. S., Lildharrie, C., Lin, E., Wang, G., & Volkow, N. D. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2423785122 · Cited by 18
Self-citationLooby, A. R., Kassman, K. T., & Earleywine, M. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.03.012 · Cited by 17
Qian, A., Tao, J., Wang, X., Liu, H., Ji, L.-X., Yang, C., Ye, Q., Chen, C., Li, J., Cheng, J., et al. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2018.00279 · Cited by 17
Möglichkeiten und Grenzen des pharmakologischen Neuroenhancements
Normann, C., Boldt, J., Maio, G., & Berger, T. (2009) · Der Nervenarzt · doi:10.1007/s00115-009-2858-2 · Cited by 24
Choi, H., Hong, J., Kang, H. G., Park, M.-H., Ha, S., Lee, J., Yoon, S., Kim, D., Park, Y. R., & Cheon, K.-A. A. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01547-9 · Cited by 21
Schwarz, R., Reif, A., Scholz, C. J., Weißflog, L., Schmidt, B., Lesch, K., Jacob, C., Reichert, S., Heupel, J., Volkert, J., et al. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.948064 · Cited by 14
Sharif, S., Fergus, S., Guirguis, A., Smeeton, N., & Schifano, F. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2888 · Cited by 13
Richer, K., Hamilton, J., Delis, F., Martin, C. D., Fricke, D., Yao, R., Sajjad, M., Blum, K., Hadjiargyrou, M., Komatsu, D. E., et al. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147799 · Cited by 11
Hadas, I., Gal, R., Bokovza, L., Meiran, N., Feifel, D., & Zangen, A. (2016) · Scientific Reports · doi:10.1038/srep21129 · Cited by 11
Methylphenidate increases glucose uptake in the brain of young and adult rats
Réus, G. Z., Scaini, G., Titus, S. E., Furlanetto, C. B., Wessler, L. B., Ferreira, G. K., Gonçalves, C. L., Jeremias, G. C., Quevedo, J., & STRECK, E. L. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.005 · Cited by 10
Vance, A. L. A., Winther, J., & Rennie, K. (2011) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2010.01941.x · Cited by 14
Chen, W., Volkow, N. D., Li, J., Pan, Y., & Du, C. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy057 · Cited by 14
Self-citationWigal, S. B., Polzonetti, C. M., Stehli, A., & Gratton, E. (2012) · Journal of Biomedical Optics · doi:10.1117/1.jbo.17.12.127002 · Cited by 12
Zoratto, F., Franchi, F., Macrì, S., & Laviola, G. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05229-9 · Cited by 8
Maier, S. J., van Elst, L. T., Philipsen, A., Lange, T., Feige, B., Glauche, V., Nickel, K., Matthies, S., Alm, B., Sobanski, E., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082601 · Cited by 11
The impact of a mental work on food preferences, eating behavior traits and satiety efficiency
Salama, M., Drapeau, V., Tremblay, A., & Pérusse-Lachance, É. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.11.015 · Cited by 11
Tremblay, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00285 · Cited by 10
A suite of neurophotonic tools to underpin the contribution of internal brain states in fMRI
Mächler, P., Broggini, T., Matéo, C., Thunemann, M., Fomin-Thunemann, N., Doran, P. R., Şencan, İ., Kılıç, K., Desjardins, M., Uhlířová, H., et al. (2021) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2021.100273 · Cited by 7
Interactions of catecholamines and GABA+ in cognitive control: Insights from EEG and 1H-MRS
Koyun, A. H., Talebi, N., Werner, A., Wendiggensen, P., Kuntke, P., Roessner, V., Beste, C., & Stock, A. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120619 · Cited by 9
Adam, L. C., Repantis, D., Konrad, B. N., Dresler, M., & Kühn, S. (2021) · Brain and Cognition · doi:10.1016/j.bandc.2021.105802 · Cited by 8
Progress in PET Imaging of the Norepinephrine Transporter System
Ding, Y. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_19 · Cited by 6
Kim, S. M., Min, K. J., & Han, D. H. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.2.259 · Cited by 8
Hill, J., Korponay, C. H., Salmeron, B. J., Ross, T. J., & Janes, A. C. (2024) · Human Brain Mapping · doi:10.1002/hbm.70086 · Cited by 4
Arnavut, E., Hamilton, J., Yao, R., Sajjad, M., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2022) · Synapse · doi:10.1002/syn.22243 · Cited by 8
Progress in PET Imaging of the Norepinephrine Transporter System
Ding, Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_20 · Cited by 7
Saleh, A. Y., Saputra, D. A. Y., Valentina, R., & Susanto, T. D. (2025) · F1000Research · doi:10.12688/f1000research.160416.3 · Cited by 4
Zorzo, C., Arias, J. L., & Méndez, M. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.02.002 · Cited by 3
Zorzo, C., Méndez, M., Pernia, A. M., & Arias, J. L. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147610 · Cited by 4
The effects of acute dopamine reuptake inhibition on cognitive function during passive hyperthermia
Wallace, P. J., Martins, R. S., Scott, J. S., Steele, S. W., Greenway, M. J., & Cheung, S. S. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0869 · Cited by 3
Impact of “noncaloric” activity-related factors on the predisposition to obesity in children
Tremblay, A., Pérusse-Lachance, E., & Brassard, P. (2010) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s7986 · Cited by 3
Hirndoping: Die Position der Deutschen Hauptstelle für Suchtfragen e.V. (DHS)
Glaeske, G., Merchlewicz, M., Schepker, R., Soellner, R., Böning, J., & Gaßmann, R. (2011) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911.a000141 · Cited by 5
Attention deficit hyperactivity disorder
McArdle, P. (2013) · Paediatrics and Child Health · doi:10.1016/j.paed.2012.11.003 · Cited by 7
Resource-rational psychopathology.
Bari, B. A., & Gershman, S. J. (2024) · Behavioral Neuroscience · doi:10.1037/bne0000600 · Cited by 5
Stormezand, G. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_30 · Cited by 2
A META-ANALYSIS OF PRESCRIPTION STIMULANT EFFICACY: ARE STIMULANTS NEUROCOGNITIVE ENHANCERS?
Marraccini, M. E. (2015) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-marraccini-marisa-2015 · Cited by 2
Metadata
- Authors
- Volkow, N. D., Fowler, J. S., Wang, G.-J., Telang, F., Logan, J., Wong, C., Ma, J., Pradhan, K., Benveniste, H., & Swanson, J. M.
- Affiliations
- National Institute on Drug Abuse (US)
- Brookhaven National Laboratory (US)
- National Institute on Alcohol Abuse and Alcoholism (US)
- University of California, Irvine (US)
- Corresponding author
- Volkow, Nora D.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-16
- Volume
- 3
- Issue
- 4
- Pages
- e2017
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2291196
- OpenAlex
- W2099355488
- Cited by
- 117
- References
- 37
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 8 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 9 · 2015: 9 · 2014: 7 · 2013: 9 · 2012: 8
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Energy (76CH00016, DE-AC01-76CH00016)
- National Institutes of Health (DE-AC01-76CH00016)
- Biological and Environmental Research
- Topics
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- methylphenidate, stimulants, brain glucose metabolism, cognitive enhancement, default mode network, mind wandering, signal-to-noise ratio, brain activation, attention deficit hyperactivity disorder, 2-deoxy-2-[18F]fluoro-D-glucose
- MeSH terms
- Adult, Central Nervous System Stimulants, Brain, Cognition, Female, Glucose, Humans, Male, Methylphenidate, Models, Theoretical, Placebos, Reproducibility of Results, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.